ARCHIVES

ACS Study Shows Reduced Mortality For Low T/N Brands

This article is from The Cancer Letter archive.

Vol. 06 No. 16 | April 18, 1980

Download PDF Visit The Full Archive

Related Articles

Robert Day Advocates NCI Payment for Investigator Salaries

May 7, 1999

MAP Says It Will Continue Operating With Private Funds

April 18, 1986

A letter about FDA oncology consolidation reopens debate among cancer groups; FDA asks groups not to send letters, invites discussion.

June 4, 2004

Celebrex Studies Show Polyp Reduction, Point To Challenges In Biomarker Validation

April 28, 2006

DCCP Board Defers Two Concept Requests, Approves Sole Sources

October 22, 1982

NCCS Networker Volume 2 Issue 4, Fall 1988

September 13, 1988